PLSE
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Pulse Biosciences completed enrollment in the PRECISE-BTN study evaluating the nPulse Vybrance percutaneous electrode system for symptomatic benign thyroid nodulesSep 15, 2026
- Pulse Biosciences passes enrollment midpoint in the pivotal NANOPULSE-AF IDE studyJul 29, 2026
- Pulse Biosciences enrolled first patients in NANOPULSE-AF pivotal studyApr 7, 2026
- Pulse Biosciences announced first patient enrollments in a feasibility study using nPulse technology to treat malignant thyroid tumorsMar 12, 2026
- Pulse Biosciences reported first-in-human clinical durability data for the nPulse Vybrance system in benign thyroid nodule ablationMar 9, 2026